JPWO2019195291A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019195291A5 JPWO2019195291A5 JP2020554448A JP2020554448A JPWO2019195291A5 JP WO2019195291 A5 JPWO2019195291 A5 JP WO2019195291A5 JP 2020554448 A JP2020554448 A JP 2020554448A JP 2020554448 A JP2020554448 A JP 2020554448A JP WO2019195291 A5 JPWO2019195291 A5 JP WO2019195291A5
- Authority
- JP
- Japan
- Prior art keywords
- rsv
- polypeptide
- antigenic
- seq
- polypeptide according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024153695A JP2024170566A (ja) | 2018-04-03 | 2024-09-06 | 抗原性呼吸器合胞体ウイルスポリペプチド |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862652199P | 2018-04-03 | 2018-04-03 | |
| US62/652,199 | 2018-04-03 | ||
| PCT/US2019/025387 WO2019195291A1 (en) | 2018-04-03 | 2019-04-02 | Antigenic respiratory syncytial virus polypeptides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024153695A Division JP2024170566A (ja) | 2018-04-03 | 2024-09-06 | 抗原性呼吸器合胞体ウイルスポリペプチド |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021519597A JP2021519597A (ja) | 2021-08-12 |
| JP2021519597A5 JP2021519597A5 (https=) | 2022-04-07 |
| JPWO2019195291A5 true JPWO2019195291A5 (https=) | 2022-04-07 |
| JP7614841B2 JP7614841B2 (ja) | 2025-01-16 |
Family
ID=66182672
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020554448A Active JP7614841B2 (ja) | 2018-04-03 | 2019-04-02 | 抗原性呼吸器合胞体ウイルスポリペプチド |
| JP2024153695A Pending JP2024170566A (ja) | 2018-04-03 | 2024-09-06 | 抗原性呼吸器合胞体ウイルスポリペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024153695A Pending JP2024170566A (ja) | 2018-04-03 | 2024-09-06 | 抗原性呼吸器合胞体ウイルスポリペプチド |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12071454B2 (https=) |
| EP (1) | EP3773704A1 (https=) |
| JP (2) | JP7614841B2 (https=) |
| KR (1) | KR20210018206A (https=) |
| CN (1) | CN112512567A (https=) |
| AU (1) | AU2019247034B2 (https=) |
| BR (1) | BR112020019938A2 (https=) |
| CA (1) | CA3095175A1 (https=) |
| MX (1) | MX2020010199A (https=) |
| WO (1) | WO2019195291A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112512566A (zh) | 2018-04-03 | 2021-03-16 | 赛诺菲 | 抗原性爱泼斯坦-巴尔病毒多肽 |
| CN112512564A (zh) | 2018-04-03 | 2021-03-16 | 赛诺菲 | 铁蛋白蛋白 |
| BR112020019938A2 (pt) | 2018-04-03 | 2021-01-26 | Sanofi | polipeptídeos antigênicos de vírus sincicial respiratório |
| MX2024005462A (es) | 2021-11-05 | 2024-05-22 | Sanofi Sa | Vacuna de arn del virus respiratorio sincitial. |
| WO2023201222A1 (en) * | 2022-04-11 | 2023-10-19 | Vanderbilt University | Ferritin nanoparticles and methods of use thereof |
| WO2024041772A1 (en) * | 2022-08-22 | 2024-02-29 | Glaxosmithkline Biologicals Sa | Rsv-f proteins |
| WO2024078597A1 (en) * | 2022-10-13 | 2024-04-18 | Rvac Medicines (Us) , Inc. | Rsv f protein variants and uses thereof |
| WO2024094881A1 (en) | 2022-11-04 | 2024-05-10 | Sanofi | Respiratory syncytial virus rna vaccination |
| US20250009865A1 (en) | 2023-05-10 | 2025-01-09 | Sanofi | Combination respiratory mrna vaccines |
| WO2025026448A1 (zh) * | 2023-08-03 | 2025-02-06 | 广州穗和生物技术有限公司 | 修饰的呼吸道合胞病毒f蛋白及其用途 |
| WO2025092933A1 (zh) * | 2023-10-31 | 2025-05-08 | 上海蓝鹊生物医药有限公司 | 一种rsv抗原、核酸、重组表达载体、药物组合物及其应用 |
| CN117586359A (zh) * | 2024-01-19 | 2024-02-23 | 北京安百胜生物科技有限公司 | 一种具有免疫原性的呼吸道合胞病毒（rsv）多肽 |
| CN120099235A (zh) * | 2025-05-09 | 2025-06-06 | 北京华诺泰生物医药科技有限公司 | 一种微生物发酵工艺的优化方法及装置 |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2142817C1 (ru) | 1993-08-06 | 1999-12-20 | Коннот Лабораториз Лимитед | Инактивированные вакцины респираторно-синцитиального вируса |
| US5585250A (en) * | 1993-08-20 | 1996-12-17 | The United States Of America As Represented By The Department Of Health & Human Services | Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies |
| ATE509102T1 (de) | 1994-07-15 | 2011-05-15 | Univ Iowa Res Found | Immunomodulatorische oligonukleotide |
| US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
| US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| WO1998037919A1 (en) | 1997-02-28 | 1998-09-03 | University Of Iowa Research Foundation | USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS |
| US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| AU7690898A (en) | 1997-05-20 | 1998-12-11 | Ottawa Civic Hospital Loeb Research Institute | Vectors and methods for immunization or therapeutic protocols |
| ATE356630T1 (de) | 1998-04-03 | 2007-04-15 | Univ Iowa Res Found | Verfahren und produkte zur stimulierung des immunsystems mittels immunotherapeutischer oligonukleotide und zytokine |
| WO2001075436A1 (en) | 2000-04-03 | 2001-10-11 | Board Of Trustees Of The Leland Stanford Junior University | A method for protein structure alignment |
| WO2002016421A2 (en) | 2000-08-18 | 2002-02-28 | Research Foundation Of The State University Of New York | Altered ospa of borrelia burgdorferi |
| EP1504037B1 (en) | 2002-05-10 | 2009-12-30 | New Century Pharmaceuticals, Inc. | Ferritin fusion proteins for use in vaccines and other applications |
| US7774185B2 (en) | 2004-09-14 | 2010-08-10 | International Business Machines Corporation | Protein structure alignment using cellular automata |
| EP1997830A1 (en) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
| AU2008339984A1 (en) | 2007-12-21 | 2009-07-02 | Glaxosmithkline Biologicals S.A. | Vaccine |
| PL2222710T3 (pl) | 2007-12-24 | 2017-01-31 | Id Biomedical Corporation Of Quebec | Rekombinowane antygeny rsv |
| WO2009126816A1 (en) | 2008-04-09 | 2009-10-15 | Ventria Bioscience | Production of ospa for lyme disease control |
| JP5813513B2 (ja) | 2008-12-09 | 2015-11-17 | ノババックス，インコーポレイテッド | 修飾ｒｓｖｆタンパク質及びその使用方法 |
| EP4218799A1 (en) | 2009-07-15 | 2023-08-02 | GlaxoSmithKline Biologicals S.A. | Rsv f protein compositions and methods for making same |
| EP3705133B1 (en) | 2010-05-14 | 2024-06-26 | Baxalta Incorporated | Ospa chimeras and use thereof in vaccines |
| WO2012006180A1 (en) | 2010-06-29 | 2012-01-12 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Hiv immunogens |
| EP2694109A4 (en) | 2011-04-07 | 2015-02-18 | Neotope Biosciences Ltd | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PROTEIN AGGREGATION DISEASES WITH IC3B DEPOSITION |
| JP5795184B2 (ja) | 2011-04-22 | 2015-10-14 | 国立大学法人 奈良先端科学技術大学院大学 | 被検物質の電気化学的検出方法 |
| EP2515112B1 (en) | 2011-04-22 | 2015-08-12 | Sysmex Corporation | Method for electrochemically detecting analyte |
| WO2013039792A1 (en) | 2011-09-12 | 2013-03-21 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Immunogens based on an hiv-1 gp120 v1v2 epitope |
| IN2014CN02114A (https=) * | 2011-09-20 | 2015-05-29 | Sinai School Medicine | |
| CA2849822C (en) | 2011-09-23 | 2021-05-11 | Gary J. Nabel, M.D. | Novel influenza hemagglutinin protein-based vaccines |
| AU2013295647B2 (en) | 2012-07-26 | 2018-02-08 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Multimeric fusion protein vaccine and immunotherapeutic |
| FI2970398T3 (fi) * | 2013-03-13 | 2024-08-06 | Us Health | Rsv f -prefuusioproteiineja ja niiden käyttö |
| US10744199B2 (en) | 2013-10-11 | 2020-08-18 | The Usa, As Represented By The Secretary, Dept. Of Health And Human Services | Epstein-Barr virus vaccines |
| CZ2014320A3 (cs) | 2014-05-09 | 2015-11-18 | VÝZKUMNÝ ÚSTAV VETERINÁRNÍHO LÉKAŘSTVÍ, v.v.i. | Polyepitopový antigen, vakcinační konstrukt a vakcína pro prevenci lymeské boreliózy |
| CA2950085A1 (en) * | 2014-05-27 | 2015-12-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Stabilized influenza hemagglutinin stem region trimers and uses thereof |
| US9703095B2 (en) | 2015-01-05 | 2017-07-11 | Edward Pakhchyan | Light modulator for MEMS display |
| WO2016138160A1 (en) * | 2015-02-24 | 2016-09-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use |
| KR20180088458A (ko) | 2015-12-04 | 2018-08-03 | 다나-파버 캔서 인스티튜트 인크. | 암의 치료를 위한 mica/b 알파 3 도메인의 백신접종 |
| US11174292B2 (en) * | 2016-03-29 | 2021-11-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Substitutions-modified prefusion RSV F proteins and their use |
| EP3463444B1 (en) | 2016-06-07 | 2024-10-16 | Deutsches Krebsforschungszentrum | Improvement of hpv l2 peptide immunogenicity |
| FI3471760T3 (fi) | 2016-06-17 | 2025-01-27 | Boehringer Ingelheim Vetmedica Gmbh | Lineaarisia tai haaroittuneita polyakryylihappopolymeeriadjuvantteja käsittäviä uusia immunogeenisiä formulaatioita |
| EP3474893A1 (en) | 2016-06-27 | 2019-05-01 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens |
| UA129243C2 (uk) | 2017-04-19 | 2025-02-26 | Інстітьют Фо Рісьорч Ін Біомедцін | Антитіло, що зв'язується зі спорозоїтами p. falciparum |
| EP3713601A4 (en) | 2017-11-21 | 2022-03-09 | Modernatx, Inc. | VACCINES AGAINST EPSTEIN-BARR VIRUS |
| BR112020019938A2 (pt) | 2018-04-03 | 2021-01-26 | Sanofi | polipeptídeos antigênicos de vírus sincicial respiratório |
| CN112512564A (zh) | 2018-04-03 | 2021-03-16 | 赛诺菲 | 铁蛋白蛋白 |
| CA3095174A1 (en) | 2018-04-03 | 2019-10-10 | Sanofi | Antigenic ospa polypeptides |
| CN112512565A (zh) | 2018-04-03 | 2021-03-16 | 赛诺菲 | 抗原性流感-铁蛋白多肽 |
| CN112512566A (zh) | 2018-04-03 | 2021-03-16 | 赛诺菲 | 抗原性爱泼斯坦-巴尔病毒多肽 |
-
2019
- 2019-04-02 BR BR112020019938-9A patent/BR112020019938A2/pt unknown
- 2019-04-02 CN CN201980036093.4A patent/CN112512567A/zh active Pending
- 2019-04-02 WO PCT/US2019/025387 patent/WO2019195291A1/en not_active Ceased
- 2019-04-02 MX MX2020010199A patent/MX2020010199A/es unknown
- 2019-04-02 CA CA3095175A patent/CA3095175A1/en active Pending
- 2019-04-02 KR KR1020207031417A patent/KR20210018206A/ko active Pending
- 2019-04-02 EP EP19718031.8A patent/EP3773704A1/en active Pending
- 2019-04-02 JP JP2020554448A patent/JP7614841B2/ja active Active
- 2019-04-02 AU AU2019247034A patent/AU2019247034B2/en active Active
-
2020
- 2020-10-01 US US17/061,065 patent/US12071454B2/en active Active
-
2024
- 2024-07-17 US US18/775,573 patent/US20250059240A1/en active Pending
- 2024-09-06 JP JP2024153695A patent/JP2024170566A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021519597A5 (https=) | ||
| Theisen et al. | Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli | |
| JPWO2019195291A5 (https=) | ||
| Gray et al. | Primary sequence of the alpha-toxin gene from Staphylococcus aureus wood 46 | |
| Aduse-Opoku et al. | Characterization, genetic analysis, and expression of a protease antigen (PrpRI) of Porphyromonas gingivalis W50 | |
| JP2021519596A5 (https=) | ||
| JP2021519599A5 (https=) | ||
| JPH0242099A (ja) | 普遍的なｔ―細胞エピトープ | |
| Tuchscherer et al. | Total chemical synthesis, characterization, and immunological properties of an MHC class I model using the TASP concept for protein de novo design | |
| JPH07126291A (ja) | 肺炎球菌表面プロテインａのエピトープ領域 | |
| EP0896583A1 (en) | Novel osp-c derived peptide fragments | |
| JPWO2019195316A5 (https=) | ||
| EP1311682A2 (en) | Recombinant constructs of borrelia burgdorferi | |
| JPH02503916A (ja) | Ｈｉｖエンベロープ蛋白質に関連する合成ペプチド | |
| Woollard et al. | Synthetic peptides induce antibody against a host-protective antigen of Echinococcus granulosus | |
| CA2148563C (en) | Purified nontypable haemophilus influenzae p5 protein as a vaccine for nontypable haemophilus influenzae strain | |
| JPWO2019195276A5 (https=) | ||
| WO2024047090A3 (en) | Modified virus-like particles of cmv | |
| CA2121121C (en) | Preparation of recombinant borrelia proteins | |
| CN101023186A (zh) | 可诱导针对金黄色葡萄球菌的保护性免疫应答的多肽 | |
| RU2009115688A (ru) | Иммуногенные гибридные полипептиды против ожирения и композиция вакцин против ожирения, содержащая эти полипептиды | |
| Schmidt et al. | Mapping of linear B-cell epitopes of the S2 subunit of pertussis toxin | |
| CA2224444C (en) | Type f botulinum toxin and use thereof | |
| EP0166548A2 (en) | Broad spectrum vaccine against gonorrhea | |
| Schmidt et al. | Gal-Gal pyelonephritis Escherichia coli pili linear immunogenic and antigenic epitopes. |